Quantbot Technologies LP Takes Position in Cigna Group $CI

Quantbot Technologies LP acquired a new stake in shares of Cigna Group (NYSE:CI) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 10,648 shares of the health services provider’s stock, valued at approximately $2,935,000.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Assetmark Inc. grew its stake in Cigna Group by 10.0% during the 1st quarter. Assetmark Inc. now owns 65,662 shares of the health services provider’s stock worth $17,515,000 after buying an additional 5,963 shares during the last quarter. Mystic Asset Management Inc. bought a new stake in Cigna Group in the second quarter valued at $2,808,000. HighTower Advisors LLC boosted its holdings in shares of Cigna Group by 402.7% during the second quarter. HighTower Advisors LLC now owns 354,398 shares of the health services provider’s stock valued at $97,701,000 after acquiring an additional 283,897 shares during the period. KBC Group NV boosted its holdings in shares of Cigna Group by 6.4% during the second quarter. KBC Group NV now owns 380,034 shares of the health services provider’s stock valued at $104,768,000 after acquiring an additional 22,978 shares during the period. Finally, Handelsbanken Fonder AB grew its position in shares of Cigna Group by 12.1% during the second quarter. Handelsbanken Fonder AB now owns 82,825 shares of the health services provider’s stock worth $22,833,000 after acquiring an additional 8,960 shares during the last quarter. Institutional investors and hedge funds own 86.99% of the company’s stock.

Cigna Group Stock Down 0.5%

Cigna Group stock opened at $276.19 on Monday. Cigna Group has a 52 week low of $239.51 and a 52 week high of $315.47. The stock has a market cap of $72.98 billion, a price-to-earnings ratio of 11.43, a PEG ratio of 0.95 and a beta of 0.29. The company’s 50-day moving average price is $284.20 and its two-hundred day moving average price is $281.45. The company has a current ratio of 0.76, a quick ratio of 0.76 and a debt-to-equity ratio of 0.68.

Cigna Group (NYSE:CI) last posted its quarterly earnings data on Thursday, July 30th. The health services provider reported $7.78 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.60 by $0.18. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The business had revenue of $70.04 billion during the quarter, compared to analysts’ expectations of $70.14 billion. During the same period last year, the firm posted $7.20 earnings per share. The business’s revenue was up 6.7% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.450- EPS. On average, analysts expect that Cigna Group will post 30.51 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th will be issued a dividend of $1.56 per share. This represents a $6.24 dividend on an annualized basis and a yield of 2.3%. The ex-dividend date of this dividend is Tuesday, September 8th. Cigna Group’s payout ratio is presently 25.82%.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on CI shares. Cantor Fitzgerald increased their price objective on shares of Cigna Group from $325.00 to $340.00 and gave the stock an “overweight” rating in a report on Friday, May 1st. Deutsche Bank Aktiengesellschaft cut shares of Cigna Group from a “buy” rating to a “hold” rating and decreased their target price for the stock from $303.00 to $302.00 in a research report on Wednesday, May 20th. UBS Group raised their price target on shares of Cigna Group from $375.00 to $400.00 and gave the company a “buy” rating in a research note on Friday, May 22nd. The Goldman Sachs Group lifted their price target on Cigna Group from $335.00 to $340.00 and gave the company a “buy” rating in a report on Monday, May 4th. Finally, Piper Sandler decreased their price objective on Cigna Group from $370.00 to $346.00 and set an “overweight” rating for the company in a report on Wednesday, June 3rd. Fifteen equities research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $339.45.

Insider Activity at Cigna Group

In related news, CAO Jamie G. Kates sold 899 shares of the business’s stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $298.61, for a total value of $268,450.39. Following the sale, the chief accounting officer directly owned 2,368 shares in the company, valued at $707,108.48. The trade was a 27.52% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Nicole S. Jones sold 19,436 shares of the stock in a transaction on Tuesday, August 4th. The shares were sold at an average price of $276.27, for a total value of $5,369,583.72. Following the sale, the insider owned 27,256 shares of the company’s stock, valued at $7,530,015.12. This trade represents a 41.63% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 23,012 shares of company stock worth $6,386,550 in the last ninety days. Corporate insiders own 0.60% of the company’s stock.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.